Investigation of Urological Cancer Biomarkers by Analyzing Exosome-derived MicroRNA

Investigation of Urological Cancer Biomarkers by Analyzing Exosome-derived MicroRNA - EMBUC study: Exosomal MicroRNA-based Biomarkers for Urinary tract Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061395

Enrollment

800

Registered

2026-04-27

Start date

2019-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal, Urothelial, and Prostate cancers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients at our institution who are currently undergoing or are expected to undergo treatment for renal, urothelial, or prostate cancer will be included. In addition, patients with benign conditions, such as urolithiasis and benign prostatic hyperplasia, who visit or are admitted for treatment will be enrolled as controls.

Exclusion criteria

Exclusion criteria: Patients without informed consent

Design outcomes

Primary

Measure	Time frame
AUC (area under the ROC curve) for discriminating cancer vs non-cancer	—

Secondary

Measure	Time frame
sensitivity and specificity	—

Countries

Japan

Contacts

Public ContactNobuyuki Tanaka

Keio University School of Medicine Department of Urology

urotanaka@keio.jp03-5363-3825

Outcome results